-

Scott+Scott Attorneys at Law LLP Announces Investigation into Owlet, Inc. (OWLT)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) and certain of its officers and directors violated federal securities laws by making materially misleading statements to investors. If you purchased or otherwise own Owlet stock, and have suffered a loss, you are encouraged to contact Scott+Scott attorney, Rhiana Swartz, at rswartz@scott-scott.com or (844) 818-6980 for more information.

On October 4, 2021, Owlet, Inc. stock fell more than 24.5% after the Company notified investors that it had received a warning letter (“Warning Letter”) from the Food and Drug Administration (“FDA”) on improper marketing of its flagship product called the Smart Sock.

The Warning Letter asserts that the Company’s marketing of its Owlet Smart Sock in the U.S. renders the Smart Sock a medical device requiring premarket clearance or approval from the FDA and that the Company has not obtained such clearance or approval. Additionally, the Warning Letter "requests the Company cease commercial distribution of the Smart Sock for uses in measuring blood oxygen saturation and pulse rate where such metrics are intended to identify or diagnose desaturation and bradycardia using an alarm functionality to notify users that measurements are outside of preset values," the Company says.

Pursuant to the Warning Letter, the Company suspended distribution of the Smart Sock in the United States as of October 22, 2021.

What You Can Do

If you purchased or otherwise own Owlet stock, and you wish to discuss this investigation, please contact attorney Rhiana Swartz at (844) 818-6980, or at rswartz@scott-scott.com, or visit the Owlet investigation page on our website at https://scott-scott.com/sec-investigation/owlet-inc/

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, Virginia, California, and Ohio.

Attorney Advertising

Contacts

Rhiana Swartz
Scott+Scott Attorneys at Law LLP
230 Park Ave, 17th Fl, New York, NY 10169
(844) 818-6980
rswartz@scott-scott.com

Scott+Scott Attorneys at Law LLP

NYSE:OWLT

Release Versions

Contacts

Rhiana Swartz
Scott+Scott Attorneys at Law LLP
230 Park Ave, 17th Fl, New York, NY 10169
(844) 818-6980
rswartz@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Corcept...

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Charming Medical Limited (NASDAQ: MCTA)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Charming Medical, Limited; Kit Wong; Ching Man Cheung; Josephine Yan Yeung; Leut Ming Gung; Shu Tai Victor Yu; Cathay Securities Inc.; WWC, P.C.; And Cogency Global, Inc. (collectively, the “Defendants”). The action, which was filed in the U.S. District Court for the Southern Dist...

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Charming Medical Limited (NASDAQ: MCTA)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Charming Medical, Limited; Kit Wong; Ching Man Cheung; Josephine Yan Yeung; Leut Ming Gung; Shu Tai Victor Yu; Cathay Securities Inc.; WWC, P.C.; And Cogency Global, Inc. (collectively, the “Defendants”). The action, which was filed in the U.S. District Court for the Southern Dist...
Back to Newsroom